Lead Principal Investigator

Bradley M. Block, M.D. is providing exceptional leadership at Oviedo Medical Research, LLC and has served as the lead principal investigator on over 130 clinical trials. He is a partner at OMR, and has over 29 years of clinical research experience in multiple therapeutic areas such as cardiovascular, pain, general medicine, gastrointestinal, immunological, endocrine, neurological, orthopedic, lipid, dermatological, pulmonary, contraceptive, pediatric, and men and women’s health.

Dr. Block has served on multiple pharmaceutical advisory boards, such as Lilly Pharmaceuticals Migraine Portfolio Advisory Board, Pfizer & Lilly Pharmaceuticals for Tanezumab Advisory Boards, Migraine Advisory Board for Pfizer Pharmaceuticals, Obesity Advisory Board for Novo Nordisk Pharmaceuticals, and a MASH Focus Group for Novo Nordisk Pharmaceuticals.

Dr. Block has been named one of Orlando’s “Best Doctors” for Family Medicine by local physicians, and published in Orlando Magazine’s “Best Doctors” most years since 2011. Dr. Block is a past Clinical Assistant Professor of the Florida State University School of Medicine. Dr. Block earned his medical degree from Temple University School of Medicine.